Valeo Financial Advisors, LLC Invitae Corp Transaction History

Valeo Financial Advisors, LLC

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 22, 2021	SELL	$26.09 - $40.4 $120,692 - $186,890	-4,626 Closed	0 $0
Q1 2021 Apr 12, 2021	BUY	$33.06 - $56.93 $2,512 - $4,326	76 Added 1.67%	4,626 $177,000
Q4 2020 Feb 11, 2021	BUY	$39.09 - $57.4 $8,404 - $12,341	215 Added 4.96%	4,550 $190,000
Q3 2020 Oct 28, 2020	BUY	$28.43 - $44.67 $7,420 - $11,658	261 Added 6.41%	4,335 $188,000
Q2 2020 Jul 20, 2020	BUY	$11.71 - $30.29 $4,684 - $12,116	400 Added 10.89%	4,074 $123,000
Q1 2020 Apr 13, 2020	SELL	$7.64 - $27.5 $6,249 - $22,495	-818 Reduced 18.21%	3,674 $49,000
Q4 2019 Jan 24, 2020	BUY	$15.02 - $20.57 $61,897 - $84,768	4,121 Added 1110.78%	4,492 $72,000
Q3 2019 Oct 15, 2019	BUY	$18.85 - $27.5 $377 - $550	20 Added 5.7%	371 $7,000
Q2 2019 Jul 10, 2019	SELL	$17.37 - $26.27 $191 - $288	-11 Reduced 3.04%	351 $8,000
Q3 2018 Nov 01, 2018	BUY	$7.54 - $18.31 $2,729 - $6,628	362 New	362 $5,000

2.12M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Valeo Financial Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Valeo Financial Advisors, LLC with notifications on news.